Navigation Links
Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
Date:2/11/2008

markets and investment losses and defaults

-- General economic downturns, major disasters, and epidemics

This list is not exhaustive. Management believes the forward-looking statements in this release are reasonable. However, there is no assurance that the actions, events or results anticipated by the forward-looking statements will occur or, if any of them do, what impact they will have on the Company's results of operations or financial condition. In view of these uncertainties, investors should not place undue reliance on any forward- looking statements, which are based on current expectations. In addition, forward-looking statements are based on information available the day they are made, and (other than as required by applicable law, including the securities laws of the United States) the Company does not intend to update or revise any of them in light of new information or future events.

Readers are advised to carefully review and consider the various disclosures in the Company's SEC reports.

Condensed Consolidated Balance Sheets

December 31, 2007 and 2006

(Dollar amounts in thousands, except per share data)

Unaudited 2007 2006

Assets

Investments $1,011,009 $900,882

Cash and cash equivalents 240,153 81,564

Premium and other receivables, net 202,268 165,626

Deferred policy acquisition costs and

value of business acquired 117,239 111,417

Property and equipment, net 43,415 41,615

Other assets 45,458 44,405

Total assets $1,659,542 $1,345,509

Liabilities and Stockholders' Equity

Policy liabili
'/>"/>

SOURCE Triple-S Management Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Triple-S Management Corporation Announces Full Exercise of Underwriters Over-Allotment Option
2. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
3. Case Management Cost-Effective Way to Cut Heart Risks
4. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
5. Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies
6. Painless Hemorrhoid Treatment Adds Management Punch
7. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
8. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
9. Standard Management Announces OTCBB Listing
10. MDS Pharma Services Wins Award for Management of Global Malaria Trial
11. AWT Management Announce Aggressive Growth and Acquisition Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Evolution of the appendix 3A A biological remnant no more 9645 1Evolution of the appendix 3A A biological remnant no more 9645 2Evolution of the appendix 3A A biological remnant no more 9645 3Georgia Reproductive Specialists Free Infertility Seminar 3A Fertility Options 101 54991 1Naren Mallakunta Joins LAXAI 13639 1Naren Mallakunta Joins LAXAI 13639 2